ABCG2 and cancer: Alteration in ABCG2 expression and activity can significantly affect the disposition of the transporter drug substrates, so it's over expression in cancer cells is responsible for decreasing in drug concentration within the cell and a reduced cancer-chemotherapy efficacy (9, 11).